1 Cardiothoracic and Vascular Health, Kolling Institute and Department of Cardiology, Royal North Shore Hospital, Northern Sydney Local Health District, Sydney, Australia.
2 Sydney Health Partners, Australia.
Eur J Prev Cardiol. 2017 Nov;24(17):1824-1830. doi: 10.1177/2047487317720287. Epub 2017 Jul 13.
Aims Identification and management of the Standard Modifiable Cardiovascular Risk Factors (SMuRFs; hypercholesterolaemia, hypertension, diabetes and smoking) has substantially improved cardiovascular disease outcomes. However, cardiovascular disease remains the leading cause of death worldwide. Suspecting an evolving pattern of risk factor profiles in the ST elevation myocardial infarction (STEMI) population with the improvements in primary care, we hypothesized that the proportion of 'SMuRFless' STEMI patients may have increased. Methods/results We performed a single centre retrospective study of consecutive STEMI patients presenting from January 2006 to December 2014. Over the study period 132/695 (25%) STEMI patients had 0 SMuRFs, a proportion that did not significantly change with age, gender or family history. The proportion of STEMI patients who were SMuRFless in 2006 was 11%, which increased to 27% by 2014 (odds ratio 1.12 per year, 95% confidence interval: 1.04-1.22). The proportion of patients with hypercholesterolaemia decreased (odds ratio 0.92, 95% confidence interval 0.86-0.98), as did the proportion of current smokers (odds ratio 0.93, 95% confidence interval 0.86-0.99), with no significant change in the proportion of patients with diabetes and hypertension. SMuRF status was not associated with extent of coronary disease; in-hospital outcomes, or discharge prescribing patterns. Conclusion The proportion of STEMI patients with STEMI poorly explained by SMuRFs is high, and is significantly increasing. This highlights the need for bold approaches to discover new mechanisms and markers for early identification of these patients, as well as to understand the outcomes and develop new targeted therapies.
识别和管理可调节的心血管危险因素(SMuRFs;高胆固醇血症、高血压、糖尿病和吸烟)已大大改善了心血管疾病的预后。然而,心血管疾病仍然是全球主要的死亡原因。鉴于初级保健水平的提高,我们推测 ST 段抬高型心肌梗死(STEMI)患者的危险因素谱可能会发生变化。方法/结果:我们对 2006 年 1 月至 2014 年 12 月连续就诊的 STEMI 患者进行了单中心回顾性研究。在研究期间,695 例 STEMI 患者中有 132 例(25%)无任何 SMuRFs,这一比例与年龄、性别或家族史无关。2006 年 STEMI 患者中无 SMuRFs 的比例为 11%,到 2014 年增至 27%(每年增加 1.12 倍,95%置信区间:1.04-1.22)。高胆固醇血症患者的比例下降(比值比 0.92,95%置信区间 0.86-0.98),当前吸烟者的比例也下降(比值比 0.93,95%置信区间 0.86-0.99),而糖尿病和高血压患者的比例无显著变化。SMuRF 状态与冠状动脉疾病的严重程度、住院期间的结局或出院时的处方模式无关。结论:不能用 SMuRFs 很好解释的 STEMI 患者比例较高,且呈显著上升趋势。这突显了需要采取大胆的方法来发现这些患者的新机制和标志物,以便早期识别这些患者,了解其结局并开发新的靶向治疗方法。